Interline Therapeutics
John Klimek has more than 15 years of experience in proteomics core facilities at the Institute for Systems Biology in Seattle and Oregon Health and Science University in Portland. Much of John’s research has centered around the creation and use of standardized test mixtures to design and improve software used in protein identification and quantification. He has also been involved with dozens of proteomics research projects using TMT labeling, which has resulted in several publications.
John’s free time is often spent with his wife and 3 kids, exploring nature and various museums and historical sites.
This person is not in the org chart
This person is not in any offices
Interline Therapeutics
Interline Therapeutics is elucidating molecular mechanisms of disease by correlating human genetics with protein community dynamics. We are developing novel drugs that target key drivers of inflammation and cancer.